Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Ggcn Polymorphism of Erf3a/Gspt1 Gene and Breast Cancer Susceptibility Publisher Pubmed



Miri M1 ; Hemati S2 ; Safari F1 ; Tavassoli M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biology, Faculty of Sciences, University of Isfahan, Hezar-Jarib, Isfahan, Iran
  2. 2. Radiation Oncology Department, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Medical Oncology Published:2012


Abstract

The significance of translation regulatory factors in elevating the risk of cancer has been recently recognized. Eukaryotic release factor 3a (eRF3a) is a translation termination protein that is encoded by G1 to S phase transition 1 gene (GSPT1). The eRF3a/GSPT1 exon 1 contains a trinucleotide GGC repeat coding for a polyglycine expansion in the N-terminal of the protein. In the present study, we determined the allelic length of the GGCn repeat in the eRF3a gene in 250 women with breast cancer and 250 age-matched controls. Our results show that the presence of the longer allele, 12-GGC, is correlated with threefold increased risk of breast cancer development. Our findings also suggest that women who are homozygous for 7-GGC allele are possibly at higher risk of developing breast cancer, especially before the age of 50. No significant effect of the allelic length of eRF3a/GSPT1 polymorphism on inheritance or the grade of this disease was observed. © Springer Science+Business Media, LLC 2011.
Other Related Docs
20. The Relationship of Cac Polymorphism in Hoxa1 Gene and Breast Cancer, Journal of Isfahan Medical School (2014)
24. Tgfbr1 Polymorphism and Risk of Breast Cancer in Iranian Women, International Journal of Biological Markers (2015)
25. Estimating Out-Of-Pocket Payments Among Iranian Women With Breast Cancer, International Journal of Cancer Management (2023)